Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,119 public trials 2,031 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

A Phase 1 Study of of Anti-CD7 Allogeneic CAR-T Cell Therapy (WU-CART-007) in Patients With Relapsed or Refractory T-ALL/LBL

NCT04984356

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • City of Hope Duarte, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Washington University St Louis, Missouri, United States
View Trial Details
Completed

Pomalidomide, Ixazomib, and Dexamethasone With or Without Intensification by Cyclophosphamide in Relapsed or Refractory Multiple Myeloma

NCT03731832

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Klinikum rechts der Isar der TU München / III. Med. Klinik und Poliklinik Munich, Bavaria, Germany
  • phase drei Hämato-Onkologischer Studienkreis am Klinikum Aschaffenburg Aschaffenburg, Germany
  • Sozialstiftung Bamberg / Klinik am Bruderwald, Zentrum für Innere Medizin, Med. Klinik V, Hämatologie und internistische Onkologie Bamberg, Germany
  • Klinikum der Johann Wolfgang Goethe-Universität Frankfurt am Main Frankfurt am Main, Germany
View Trial Details
Completed

Financial Difficulty in Patients With Blood Cancer

NCT05212233

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +22 more
Locations
  • University Of Alabama At Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Cancer Center Phoenix, Arizona, United States
  • Lewis Cancer and Research Pavilion at Saint Joseph's/Candler Savannah, Georgia, United States
  • LSU Health Baton Rouge-North Clinic Baton Rouge, Louisiana, United States
View Trial Details
Completed

A Phase 3 Open Label Randomized Study to Compare the Efficacy and Safety of Rituximab Plus Lenalidomide (CC-5013) Versus Rituximab Plus Chemotherapy Followed by Rituximab in Subjects With Previously Untreated Follicular Lymphoma

NCT01650701

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Concord Repatriation General Hospital Concord, New South Wales, Australia
  • Nepean Hospital Penrith, New South Wales, Australia
  • Wollongong Hospital Wollongong, New South Wales, Australia
  • CHU Mont-Godinne Yvoir, Belgium
View all 35 locations
View Trial Details

Related conditions